Cambridge, MA · Founded 2020 · Privately Held (backing)
Operator of a biotechnology company intended to build a hypothesis-free drug discovery and diagnostics platform for human health care advancement. Transition Bio is based in Cambridge, MA and was founded in 2020. Its last known valuation is $26.8 million. It has raised $76.5 million across 3 recorded rounds; the latest was a $13.3 million early-stage round in Oct 2024.
Last price · $/share
—
Implied valuation
$26.8M
Total raised
$76.5M
Last round
Early Stage VC
Oct 2024
Team — not yet on record
No current team members for Transition Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Transition Bio with a free account
·Watch Transition Bio: the Monday email on marks, rounds and moves
